| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 3 securities · may seek to influence control | ||||||
|
Transact Technologies Inc
13D/A
TACT · 892918103
|
4.3% |
9/24/2025
Event 9/22/2025
|
||||
| Harbert Discovery Fund LP | 4.3% | |||||
| Harbert Discovery Fund GP, LLC | 4.3% | |||||
| Harbert Fund Advisors, Inc. | 4.3% | |||||
| Harbert Management Corporation | 4.3% | |||||
| Bryant John F. | 4.3% | |||||
| Lucas Kenan | 4.3% | |||||
| Harbert Raymond J. | 4.3% | |||||
|
Streamline Health Solutions Inc.
13D/A
STRM · 86323X205
|
0% |
8/14/2025
Event 8/12/2025
|
||||
| Harbert Discovery Fund, LP | 0% | |||||
| Harbert Discovery Fund GP, LLC | 0% | |||||
| Harbert Fund Advisors, Inc. | 0% | |||||
| Harbert Management Corporation | 0% | |||||
| Jack Bryant | 0% | |||||
| Kenan Lucas | 0% | |||||
| Raymond Harbert | 0% | |||||
|
Enzo Biochem, Inc.
13D/A
ENZB · 294100102
|
9.9% |
6/25/2025
Event 6/23/2025
|
||||
| Harbert Discovery Fund, LP | 3.4% | |||||
| Harbert Discovery Fund GP, LLC | 3.4% | |||||
| Harbert Discovery Co-Investment Fund I, LP | 6.5% | |||||
| Harbert Discovery Co-Investment Fund I GP, LLC | 6.5% | |||||
| Harbert Fund Advisors, Inc. | 9.9% | |||||
| Harbert Management Corporation | 9.9% | |||||
| Jack Bryant | 9.9% | |||||
| Kenan Lucas | 9.9% | |||||
| Raymond Harbert | 9.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.